BackClínica Baviera, S.A. Overview
Clínica Baviera, S.A.

Clínica Baviera, S.A. Return on Equity

Latest ROE for Clínica Baviera, S.A.: 41.53% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

41.53%

Return on Equity

41.53%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Clínica Baviera, S.A. (CBAV.MC) FAQ

Clínica Baviera, S.A.'s return on equity stands at 41.53%. That is above the sector sector average of 11.64%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Clínica Baviera, S.A. sits higher the its sector benchmark (11.64%) with a ROE of 41.53%. That is roughly 256.9% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 41.53% for Clínica Baviera, S.A. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Clínica Baviera, S.A.'s ROE evolved across reporting periods, while the comparison chart places CBAV.MC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.